Anhui Wanbang Pharmaceutical Technology Co Ltd
301520
Company Profile
Business description
Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of drugs, improved new drugs, and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services, and data statistics and analysis.
Contact
No. 299, Huolongdi Road
High-tech Zone, , Anhui Province
Hefei230031
CHNT: +86 55168858187
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
362
Stocks News & Analysis
stocks
The ASX player evolving into a defensive haven
A well-timed simplification journey as boring evolves back in vogue.
stocks
12 picks for an income portfolio - Q1 2026 update
Passive income growth continues to exceed my target.
stocks
Strong guidance from undervalued ASX share
Shares surged after the announcement of first half fiscal 2026 guidance.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,174.10 | 12.00 | 0.13% |
| CAC 40 | 8,338.98 | 86.15 | -1.02% |
| DAX 40 | 24,469.30 | 232.94 | -0.94% |
| Dow JONES (US) | 49,428.49 | 18.94 | -0.04% |
| FTSE 100 | 10,620.08 | 47.55 | -0.45% |
| HKSE | 26,361.07 | 200.74 | 0.77% |
| NASDAQ | 24,367.85 | 100.63 | -0.41% |
| Nikkei 225 | 58,824.89 | 348.99 | 0.60% |
| NZX 50 Index | 12,915.45 | 9.78 | 0.08% |
| S&P 500 | 7,112.66 | 13.40 | -0.19% |
| S&P/ASX 200 | 8,953.30 | 13.60 | 0.15% |
| SSE Composite Index | 4,082.13 | 30.70 | 0.76% |